HealthDay - WEDNESDAY, June 25 (HealthDay News) -- Canadian researchers
report that a gene variant that seems to affect the severity of
attention-deficit hyperactivity pandemoniacal did not help them predict
which patients are likely to respond to a class of drugs widely used to
treat the disorder.

More: - Read More